CCR5 inhibitors: promising yet challenging.
Clotet
Bonaventura
B
D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000494:pharmacology; D065100:CCR5 Receptor Antagonists; D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control; D015497:HIV-1 / Q000145:classification / Q000187:drug effects*; D006801:Humans
D044966:Anti-Retroviral Agents; D065100:CCR5 Receptor Antagonists